AU2511101A - A process for preparing an autologous platelet gel and membranes thereof, and a kit for carrying out this process - Google Patents

A process for preparing an autologous platelet gel and membranes thereof, and a kit for carrying out this process

Info

Publication number
AU2511101A
AU2511101A AU25111/01A AU2511101A AU2511101A AU 2511101 A AU2511101 A AU 2511101A AU 25111/01 A AU25111/01 A AU 25111/01A AU 2511101 A AU2511101 A AU 2511101A AU 2511101 A AU2511101 A AU 2511101A
Authority
AU
Australia
Prior art keywords
membranes
kit
preparing
carrying
autologous platelet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25111/01A
Other languages
English (en)
Inventor
Marco Bellanda
Maria Cristina Sacchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2511101A publication Critical patent/AU2511101A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/0005—Ingredients of undetermined constitution or reaction products thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Surgical Instruments (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • External Artificial Organs (AREA)
AU25111/01A 1999-12-14 2000-12-13 A process for preparing an autologous platelet gel and membranes thereof, and a kit for carrying out this process Abandoned AU2511101A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITAL99U0010 1999-12-14
IT1999AL000010U ITAL990010U1 (it) 1999-12-14 1999-12-14 Nuova metodica di laboratorio per preparare gel e membrane piastriniche ottenute dal concentrato piastrinico.
PCT/EP2000/012661 WO2001043787A2 (en) 1999-12-14 2000-12-13 A process for preparing an autologous platelet gel and membrane thereof

Publications (1)

Publication Number Publication Date
AU2511101A true AU2511101A (en) 2001-06-25

Family

ID=11333478

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25111/01A Abandoned AU2511101A (en) 1999-12-14 2000-12-13 A process for preparing an autologous platelet gel and membranes thereof, and a kit for carrying out this process

Country Status (12)

Country Link
US (1) US6841170B2 (enExample)
EP (1) EP1239895B1 (enExample)
JP (1) JP2003516815A (enExample)
AT (1) ATE237370T1 (enExample)
AU (1) AU2511101A (enExample)
CA (1) CA2393315C (enExample)
DE (1) DE60002231T2 (enExample)
DK (1) DK1239895T3 (enExample)
ES (1) ES2197125T3 (enExample)
IT (1) ITAL990010U1 (enExample)
PT (1) PT1239895E (enExample)
WO (1) WO2001043787A2 (enExample)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003017913A1 (en) * 2001-08-27 2003-03-06 The Cleveland Clinic Foundation Compositions, methods and apparatus for surgical procedures
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
DE10392686T5 (de) 2002-05-24 2005-07-07 Biomet Mfg. Corp., Warsaw Vorrichtung und Verfahren zum Trennen und Konzentrieren von Flüssigkeiten, welche mehrere Komponenten enthalten
ITMI20021917A1 (it) * 2002-09-10 2004-03-11 New Dawn Consultores E Servicos L Da Attivatore per la formazione di gel piastrinico, gel di plasma povero di piastrine o gel di plasma ricco di piastrine.
ITRM20030467A1 (it) * 2003-10-10 2005-04-11 Advance Holdings Ltd Contenitore monouso per la centrifugazione ed il trattamento di un materiale biologico fluido.
US20060095121A1 (en) * 2004-10-28 2006-05-04 Medtronic Vascular, Inc. Autologous platelet gel on a stent graft
ES2426172T3 (es) * 2005-02-07 2013-10-21 Hanuman Llc Dispositivo concentrador de plasma
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
US20070087061A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components
US20070086958A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Formation of medically useful gels comprising microporous particles and methods of use
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
ES2324438B1 (es) * 2006-06-19 2010-05-25 Lorente Alvarez-Beigbeder, S.L. Metodo para la obtencion de plaquetas.
US20080255041A1 (en) * 2007-04-11 2008-10-16 Ebi, L.P. Treatment of annulus fibrosis defects
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
US7806276B2 (en) 2007-04-12 2010-10-05 Hanuman, Llc Buoy suspension fractionation system
EP2259774B1 (en) 2008-02-27 2012-12-12 Biomet Biologics, LLC Methods and compositions for delivering interleukin-1 receptor antagonist
EP2254991B1 (en) 2008-02-29 2018-08-22 Biomet Manufacturing, LLC A system and process for separating a material
ITFI20080070A1 (it) 2008-04-04 2009-10-05 Azienda Ospedaliero Universitaria Careggi Matrice extracellulare comprendente fattori piastrinici.
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
EP2470229B1 (en) 2009-06-11 2017-08-23 Universitat Autònoma De Barcelona Use of gelled prp (platelet gel) for volumetric breast reconstruction
IT1394570B1 (it) 2009-07-02 2012-07-05 Fidia Farmaceutici Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni.
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9555171B2 (en) 2010-09-30 2017-01-31 Depuy Mitek, Llc Methods and devices for collecting separate components of whole blood
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device
US20170369845A1 (en) * 2014-12-31 2017-12-28 Anthrogenesis Corporation Methods for isolation of platelets
IT201700024672A1 (it) * 2017-03-06 2018-09-06 Caloprisco Gaetano Ditta Individuale Metodo e sistema per preparare un kit medicale per curare lesioni tissutali di un paziente
US11767511B2 (en) 2018-11-30 2023-09-26 Cellphire, Inc. Platelets as delivery agents
EP3887402A4 (en) 2018-11-30 2022-10-26 Cellphire, Inc. PLATELETS AS RELEASING AGENT
US11529587B2 (en) 2019-05-03 2022-12-20 Cellphire, Inc. Materials and methods for producing blood products
US20210308066A1 (en) 2020-02-04 2021-10-07 Cellphire, Inc. Anti-fibrinolytic loaded platelets
CA3150936A1 (en) 2019-08-16 2021-02-25 Cellphire, Inc. Thrombosomes as an antiplatelet agent reversal agent
US20220273724A1 (en) 2021-02-17 2022-09-01 Cellphire Inc. Freeze-dried platelet derivative compositions for treating antiplatelet induced coagulopathy
CN114831770A (zh) * 2022-05-20 2022-08-02 上海浦灵生物科技有限公司 一种肺动脉高压非人灵长类动物模型及其构建方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
US5733545A (en) * 1995-03-03 1998-03-31 Quantic Biomedical Partners Platelet glue wound sealant
IT1284550B1 (it) 1996-09-18 1998-05-21 Flavio Tarantino Procedimento per la preparazione di colla di fibrina autologa ad uso chirurgico

Also Published As

Publication number Publication date
DE60002231D1 (de) 2003-05-22
EP1239895B1 (en) 2003-04-16
WO2001043787A2 (en) 2001-06-21
CA2393315C (en) 2010-01-26
WO2001043787A3 (en) 2001-12-13
US20020172666A1 (en) 2002-11-21
EP1239895A2 (en) 2002-09-18
ITAL990010U1 (it) 2001-06-14
PT1239895E (pt) 2003-08-29
DE60002231T2 (de) 2004-04-29
JP2003516815A (ja) 2003-05-20
ATE237370T1 (de) 2003-05-15
WO2001043787B1 (en) 2002-01-10
CA2393315A1 (en) 2001-06-21
DK1239895T3 (da) 2003-07-21
ES2197125T3 (es) 2004-01-01
US6841170B2 (en) 2005-01-11

Similar Documents

Publication Publication Date Title
AU2511101A (en) A process for preparing an autologous platelet gel and membranes thereof, and a kit for carrying out this process
AU1941197A (en) Tissue adhesive suitable for spray application
MX9603285A (es) Concentrado de plasma y composiciones obturadoras de tejido y metodos y aparatos para preparar el concentrado de plasma y/o el obturador de tejido para sellar el tejido, para la separacion rapida de particulas de suspensiones y para la concentracion
AU7116887A (en) Tricalcium phosphate for implant materials
WO1999015209A3 (en) Fibrin sponge
DK0748337T3 (da) Fremgangsmåde til fremstilling af et biologisk klæbestof indeholdende fibrinogen, faktor XIII og fibronectin
CA2113663A1 (en) Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation
DE59902496D1 (de) Fibrinklebergranulat und verfahren zu dessen herstellung
AU5459199A (en) Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
ES2194869T3 (es) Composicion adhesiva biologica y uso de la misma.
EP0341007A3 (en) Surgical adhesive material
ZA975851B (en) Hepatocyte grown factor receptor agonists and uses thereof
ES2144999T3 (es) Procedimiento para la preparacion de l-leucina terciaria mediante transaminacion.
AU7928087A (en) Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs
EP0230945A3 (en) Thrombin-binding substance and process for preparing thethrombin-binding substance and process for preparing the same same
DK1124589T3 (da) Formulering af fibrin-vævsklæber og fremgangsmåde til fremstilling af denne
DE3887303D1 (de) An Kollagen und Kalzium haftende Adhäsivzusammensetzung.
AU2528892A (en) Improved tissue glue prepared by using cryoprecipitate
TW337997B (en) Pharmaceutical preparation containing plasminogen activators
AU3806695A (en) Biomaterial containing epithelial cells and use thereof as a transplant
AU569896B2 (en) Process for the dissolution of peptides and proteins
AU3522089A (en) Combination of angiotensin converting enzyme inhibitors with potassium channel modulators and use thereof in pharmaceuticals
ATE211002T1 (de) Dextrinhaltige mischung zur verhinderung von chirurgischen verklebungen
IT8447751A0 (it) Composizione contenente polisaccaride per legare proteine specifiche, metodo per ottenerla e procedimento nonche' corredo di saggio che la impiegano
DE59805246D1 (de) Tissue-faktor zur beeinflussung von gefässbildung

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase